[1] SEWELL W H, KOTH D R, HUGGINS C E. Ventricular fibrillation in dogs after sudden return of flow to the coronary artery[J]. Surgery,1955,38(6):1050-1053.
[2] RANA A, GOYAL N, AHLAWAT A, et al. Mechanisms involved in attenuated cardio-protective role of ischemic preconditioning in metabolic disorders[J]. Perfusion,2015,30(2):94-105. doi:  10.1177/0267659114536760
[3] 陈福晖, 刘达兴, 容松. 心肌缺血再灌注损伤发生机制的研究进展[J]. 安徽医药, 2017, 21(12):2145-2148. doi:  10.3969/j.issn.1009-6469.2017.12.003
[4] CHANG G L, ZHANG D Y, YU H, et al. Cardioprotective effects of exenatide against oxidative stress-induced injury[J]. Int J Mol Med,2013,32(5):1011-1020. doi:  10.3892/ijmm.2013.1475
[5] 宋旭辉. Decorin在脑缺血防治中的功能及机制研究[D]. 上海: 第二军医大学, 2010.
[6] 吴立玲, 张幼怡. 心血管病理生理学[M]. 北京: 北京大学医学出版社, 2009: 8.
[7] 康红钰, 张福华, 刘喜民, 等. 升陷汤对大鼠急性心肌缺血作用机制的探讨[J]. 中国医院药学杂志, 2007, 27(5):617-619. doi:  10.3321/j.issn:1001-5213.2007.05.018
[8] 张万义, 邱云卿, 张万芬. 升补宗气法治疗老年慢性充血性心力衰竭疗效观察[J]. 中国中西医结合杂志, 2004, 24(1):43. doi:  10.3321/j.issn:1003-5370.2004.01.035
[9] 裴天仙, 徐长庆, 李滨, 等. 槲皮素对阿霉素致小鼠心肌损伤的保护作用及其机制[J]. 药学学报, 2007, 42(10):1029-1033. doi:  10.3321/j.issn:0513-4870.2007.10.004
[10] 曹洪欣, 朱海燕. 大气下陷证与病毒性心肌炎相关性机理的理论探讨[J]. 陕西中医, 2002, 23(2):141. doi:  10.3969/j.issn.1000-7369.2002.02.035
[11] 曹洪欣, 朱海燕. 益气升陷法治疗病毒性心肌炎的辨治要点[J]. 中医药学报, 2002, 30(5):18-19. doi:  10.3969/j.issn.1002-2392.2002.05.010
[12] 满缓, 张凤, 黄豆豆, 等. 升陷汤及各单味药对阿霉素致心肌细胞损伤的保护作用[J]. 药学实践杂志, 2019, 37(4):304-308. doi:  10.3969/j.issn.1006-0111.2019.04.004
[13] THANDROYEN F T, BELLOTTO D, KATAYAMA A, et al. Subcellular electrolyte alterations during progressive hypoxia and following reoxygenation in isolated neonatal rat ventricular myocytes[J]. Circ Res,1992,71(1):106-119. doi:  10.1161/01.RES.71.1.106
[14] MIMURO S, KATOH T, SUZUKI A, et al. Deterioration of myocardial injury due to dexmedetomidine administration after myocardial ischaemia[J]. Resuscitation,2010,81(12):1714-1717. doi:  10.1016/j.resuscitation.2010.07.021
[15] MIYAMAE M, CAMACHO S A, WEINER M W, et al. Attenuation of postischemic reperfusion injury is related to prevention of [Ca2+]m overload in rat hearts[J]. Am J Physiol,1996,271(5 Pt 2):H2145-H2153.
[16] HAUSENLOY D J, YELLON D M. Myocardial ischemia-reperfusion injury: a neglected therapeutic target[J]. J Clin Invest,2013,123(1):92-100. doi:  10.1172/JCI62874
[17] JIANG J T, YUAN X, WANG T, et al. Antioxidative and cardioprotective effects of total flavonoids extracted from Dracocephalum moldavica L. against acute ischemia/reperfusion-induced myocardial injury in isolated rat heart[J]. Cardiovasc Toxicol,2014,14(1):74-82. doi:  10.1007/s12012-013-9221-3
[18] ZHOU M J, REN H H, HAN J C, et al. Protective effects of kaempferol against myocardial ischemia/reperfusion injury in isolated rat heart via antioxidant activity and inhibition of glycogen synthase kinase-3β[J]. Oxid Med Cell Longev,2015,2015:481405.
[19] MOENS A L, CLAEYS M J, TIMMERMANS J P, et al. Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process[J]. Int J Cardiol,2005,100(2):179-190. doi:  10.1016/j.ijcard.2004.04.013
[20] MOZAFFARI M S, LIU J Y, ABEBE W, et al. Mechanisms of load dependency of myocardial ischemia reperfusion injury[J]. Am J Cardiovasc Dis,2013,3(4):180-196.
[21] NEUHOF C, NEUHOF H. Calpain system and its involvement in myocardial ischemia and reperfusion injury[J]. World J Cardiol,2014,6(7):638-652. doi:  10.4330/wjc.v6.i7.638
[22] ZHANG F, ZHAN Q, DONG X, et al. Shengxian decoction in chronic heart failure treatment and synergistic property of Platycodonis Radix: a metabolomic approach and its application[J]. Mol Biosyst,2014,10(8):2055-2063. doi:  10.1039/C4MB00055B
[23] ZHANG F, ZHAN Q, GAO S H, et al. Chemical profile- and pharmacokinetics-based investigation of the synergistic property of platycodonis Radix in traditional Chinese medicine For Mula Shengxian decoction[J]. J Ethnopharmacol,2014,152(3):497-507. doi:  10.1016/j.jep.2014.01.033
[24] 杨承芝, 朱爱华. 浅析张锡纯大气下陷证与升陷汤[J]. 中国中医药现代远程教育, 2014, 12(14):116-117. doi:  10.3969/j.issn.1672-2779.2014.14.072